Clinical Trial

Brain Connectivity Marker for Alzheimer's Disease

Name: Brain Connectivity Marker for Alzheimer's Disease — clinical trial record (NCT06874231)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BRAINCONN

Recruiting

View on ClinicalTrials.gov →

Summary

The main purpose of this project is to establish whether changes in brain connectivity can be used to predict the development of Alzheimer's disease (AD).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-11.

Trial Details

NCT Number	NCT06874231
Lead Sponsor	Karolinska Institutet Collaborators: The Swedish Research Council
Conditions	Alzheimer Disease
Enrollment	120 participants
Start Date	2023-04-01
Primary Completion	2027-07-31 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-17